What are TransMedics Group, Inc.'s profit margins?

TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.

Where do TransMedics Group, Inc.'s ratios come from?

Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

TransMedics Group, Inc. TMDX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	59.1%-0.8pp	59.9%-0.4pp	60.3%+0.5pp	59.8%+0.3pp	59.5%+0.1pp
Operating margin	14.9%-3.1pp	17.9%+1.0pp	16.9%+2.5pp	14.4%+3.7pp	10.8%+2.3pp
Net margin	27%-4.4pp	31.4%+15.2pp	16.2%+2.7pp	13.5%+3.5pp	10%+2.0pp
EBITDA margin	20%-2.4pp	22.4%+1.0pp	21.4%+2.5pp	18.9%+3.7pp	15.2%+2.2pp
Free cash flow margin	23.8%+1.7pp	22.1%—	——	——	——
Returns
Return on equity	45.2%-9.0pp	54.2%+21.8pp	32.5%+4.3pp	28.2%+5.2pp	23%+3.6pp
Return on assets	15.1%-5.2pp	20.3%+9.7pp	10.6%+1.9pp	8.7%+2.4pp	6.3%+1.6pp
Return on invested capital	40.5%—	——	——	——	——
Efficiency
Asset turnover	0.6×-0.1×	0.6×0.0×	0.7×0.0×	0.6×0.0×	0.6×0.0×
Inventory turnover	5.6×+0.5×	5.1×+0.4×	4.7×-0.2×	4.9×+0.6×	4.3×+0.4×
Liquidity
Current ratio	6.7×-0.4×	7.1×-0.5×	7.7×-2.2×	9.9×+0.8×	9.1×+0.8×
Quick ratio	6.2×-0.4×	6.6×-0.5×	7.1×-2.0×	9.2×+0.9×	8.3×+0.8×
Cash ratio	5×-0.4×	5.5×-0.4×	5.8×-1.2×	7.1×+1.5×	5.6×0.0×
Leverage
Debt-to-equity	0.8×+0.7×	0.1×0.0×	0.2×0.0×	0.2×0.0×	0.3×0.0×
Debt-to-assets	0.3×+0.2×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Net debt / EBITDA	-0.4×+2.7×	-3.1×+0.2×	-3.3×0.0×	-3.3×-0.1×	-3.3×+1.4×
Interest coverage	5.4×-2.5×	7.9×+1.0×	6.9×+1.4×	5.4×+1.7×	3.7×+1.1×
Per Share
Book value per share	$13.65+17.0%	$11.67+33.9%	$8.72+11.1%	$7.84+17.5%	$6.67+2.8%
Valuation
Market capitalization	$3.41B-18.0%	$4.16B+8.7%	$3.82B-14.8%	$4.49B+98.2%	$2.26B+8.2%
Enterprise value	$3.36B-10.1%	$3.74B+9.0%	$3.43B-17.5%	$4.15B+105%	$2.02B+10.9%
Price / earnings	19.8×-2.0×	21.8×-19.8×	41.7×-20.9×	62.6×+16.4×	46.3×-12.7×
Price / sales	5.4×-1.5×	6.9×+0.1×	6.8×-1.7×	8.4×+3.8×	4.6×-0.1×
Price / book	6.9×-1.9×	8.8×-2.0×	10.8×-3.3×	14.1×+5.6×	8.5×-0.6×
EV / EBITDA	26.4×-1.1×	27.5×-0.7×	28.2×-13.2×	41.4×+14.1×	27.3×-4.6×
EV / sales	5.3×-0.9×	6.2×+0.1×	6×-1.8×	7.8×+3.7×	4.1×0.0×
Free cash flow yield	4.4%+1.2pp	3.2%—	——	——	——
Earnings yield	5%+0.5pp	4.6%+2.2pp	2.4%+0.8pp	1.6%-0.6pp	2.2%+0.5pp
PEG ratio	0.1×0.0×	0.1×—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about TransMedics Group, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are TransMedics Group, Inc.'s profit margins?: TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.
Where do TransMedics Group, Inc.'s ratios come from?: Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.